Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Siva R Uppalapati

TitlePost-Doctoral Fellow
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
ORCID ORCID Icon0000-0002-4743-7248 Additional info

    Collapse Biography 
    Collapse education and training
    Indian Institute of Technology Roorkee, IndiaPostdoc03/2021Host-pathogen interactions
    Temple University, USAPostdoc12/2017Viral infection and immunology
    Bharathiar University, IndiaPhD10/2015Microbiology
    Sri Sathya Sai University, IndiaMSc. Hons.06/2009Biotechnology

    Collapse Overview 

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Venkataramana M, Rashmi R, Uppalapati SR, Chandranayaka S, Balakrishna K, Radhika M, Gupta VK, Batra HV. Corrigendum: Development of sandwich dot-ELISA for specific detection of Ochratoxin A and its application on to contaminated cereal grains originating from India. Front Microbiol. 2023; 14:1194327. PMID: 37915856.
      View in: PubMed
    2. Kant S, Till JKA, Liu L, Margolis A, Uppalapati S, Kim JS, Vazquez-Torres A. Gre factors help Salmonella adapt to oxidative stress by improving transcription elongation and fidelity of metabolic genes. PLoS Biol. 2023 04; 21(4):e3002051. PMID: 37014914.
      View in: PubMed
    3. Uppalapati SR, Vazquez-Torres A. Manganese Utilization in Salmonella Pathogenesis: Beyond the Canonical Antioxidant Response. Front Cell Dev Biol. 2022; 10:924925. PMID: 35903545.
      View in: PubMed
    4. Uppalapati SR, Sett A, Pathania R. The Outer Membrane Proteins OmpA, CarO, and OprD of Acinetobacter baumannii Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human Pathogen. Front Microbiol. 2020; 11:589234. PMID: 33123117.
      View in: PubMed
    5. Singh K, Singh AK, Uppalapati SR, Kingston JJ, Parida M. Immunogenicity and protective efficacy of Burkholderia pseudomallei BLF1-N and BLF1-C terminal domains against BLF1 toxin. Int Immunopharmacol. 2019 Dec; 77:105917. PMID: 31675617.
      View in: PubMed
    6. Babu L, Uppalapati SR, Sripathy MH, Reddy PN. Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model. Front Microbiol. 2017; 8:1805. PMID: 28979250.
      View in: PubMed
    7. Milora KA, Uppalapati SR, Sanmiguel JC, Zou W, Jensen LE. Interleukin-36? provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses. Sci Rep. 2017 07 19; 7(1):5799. PMID: 28724920.
      View in: PubMed
    8. Venkataramana M, Rashmi R, Uppalapati SR, Chandranayaka S, Balakrishna K, Radhika M, Gupta VK, Batra HV. Development of sandwich dot-ELISA for specific detection of Ochratoxin A and its application on to contaminated cereal grains originating from India. Front Microbiol. 2015; 6:511. PMID: 26074899.
      View in: PubMed
    9. Chitradevi ST, Kaur G, Uppalapati S, Yadav A, Singh D, Bansal A. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection. Cell Mol Immunol. 2015 Nov; 12(6):757-67. PMID: 25640657.
      View in: PubMed
    10. Shreya D, Uppalapati SR, Kingston JJ, Sripathy MH, Batra HV. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model. Mol Immunol. 2015 May; 65(1):51-7. PMID: 25645504.
      View in: PubMed
    11. Uppalapati SR, Kingston JJ, Murali HS, Batra HV. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein. Vaccine. 2014 May 23; 32(25):3075-81. PMID: 24699467.
      View in: PubMed
    12. Priyanka SR, Uppalapati SR, Kingston JJ, Murali HS, Batra HV. Development of ISSR-derived SCAR marker-targeted PCR for identification of Aspergillus section Flavi members. Lett Appl Microbiol. 2014 May; 58(5):414-22. PMID: 24313443.
      View in: PubMed
    13. Uppalapati SR, Kingston JJ, Qureshi IA, Murali HS, Batra HV. In silico, in vitro and in vivo analysis of binding affinity between N and C-domains of Clostridium perfringens alpha toxin. PLoS One. 2013; 8(12):e82024. PMID: 24349173.
      View in: PubMed
    14. Ramakrishna US, Kingston JJ, Harishchandra Sripathi M, Batra HV. Taguchi optimization of duplex PCR for simultaneous identification of Staphylococcus aureus and Clostridium perfringens alpha toxins. FEMS Microbiol Lett. 2013 Mar; 340(2):93-100. PMID: 23278425.
      View in: PubMed
    15. Rashmi R, Ramana MV, Shylaja R, Uppalapati SR, Murali HS, Batra HV. Evaluation of a multiplex PCR assay for concurrent detection of four major mycotoxigenic fungi from foods. J Appl Microbiol. 2013 Mar; 114(3):819-27. PMID: 23216688.
      View in: PubMed
    16. Uppalapati SR, Kingston JJ, Murali HS, Batra HV. Generation and characterization of an inter-generic bivalent alpha domain fusion protein aCS from Clostridium perfringens and Staphylococcus aureus for concurrent diagnosis and therapeutic applications. J Appl Microbiol. 2012 Aug; 113(2):448-58. PMID: 22563989.
      View in: PubMed
    Uppalapati's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)